(Z)-Endoxifen and Early Recurrence of Breast Cancer: An Explorative Analysis in a Prospective Brazilian Study

Adherence to treatment and use of co-medication, but also molecular factors such as CYP2D6 genotype, affect tamoxifen metabolism, with consequences for early breast cancer prognosis. In a prospective study of 149 tamoxifen-treated early-stage breast cancer patients from Brazil followed up for 5 year...

Descripción completa

Detalles Bibliográficos
Autores principales: Almeida, Thais, Schroth, Werner, Nardin, Jeanine, Mürdter, Thomas E., Winter, Stefan, Picolotto, Solane, Hoppe, Reiner, Kogin, Jenifer, Gaio, Elisa, Dasenbrock, Angela, Skrsypcsak, Raquel Cristina, de Noronha, Lucia, Schwab, Matthias, Brauch, Hiltrud, Casali-da-Rocha, José Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030524/
https://www.ncbi.nlm.nih.gov/pubmed/35455627
http://dx.doi.org/10.3390/jpm12040511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030524/
https://www.ncbi.nlm.nih.gov/pubmed/35455627
http://dx.doi.org/10.3390/jpm12040511

Ejemplares similares